January 11-14, 2027 | San Francisco Marriott Marquis
January 15, 2027 | Virtual
January 11-14, 2027 | San Francisco
January 15, 2027 | Virtual
January 11-14, 2027 | San Francisco Marriott Marquis
January 15, 2027 | Virtual
2027 Participating Companies
Synaffix - A Lonza Company
Synaffix has established a proprietary, clinical-stage platform antibody-drug conjugate (ADC) technology that delivers superior safety and efficacy compared to all 3 major clinical-stage ADC technologies. Our business model is technology out-licensing.